Publication Name	World Journal of Hepatology
Manuscript ID	91259
Country	United States

Received	2023-12-26 01:53
Peer-Review Started	2023-12-26 01:53
To Make the First Decision
Return for Revision	2024-01-11 06:32
Revised	2024-01-19 16:08
Second Decision	2024-02-28 02:47
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-02-28 07:31
Articles in Press	2024-02-28 07:31
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-03-13 03:26
Publish the Manuscript Online	2024-03-27 13:28

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Systematic Reviews
Article Title	Update in lean metabolic dysfunction-associated steatotic liver disease
Manuscript Source	Invited Manuscript
All Author List	Karina Sato-Espinoza, Perapa Chotiprasidhi, Mariella R Huaman and Javier Díaz Ferrer
ORCID	Author(s) ORCID Number Karina Sato-Espinoza http://orcid.org/0000-0002-1725-5865
Funding Agency and Grant Number
Corresponding Author	Karina Sato-Espinoza, MD, Research Fellow, Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, 200 First ST SW , Rochester, Rochester, MN 55902, United States. sato.angela@mayo.edu
Key Words	Lean; Non-obese; Non-alcoholic fatty liver disease; Metabolic dysfunction-associated fatty liver disease; Metabolic dysfunction-associated steatosis liver disease; Guidelines; Diagnosis; Management; Pathogenesis; Treatment
Core Tip	Steatotic liver disease, extensively studied in overweight/obese patients, poses a unique challenge in lean individuals due to limited data on its pathogenesis, diagnosis, management, and risk factors. The lack of consensus in nomenclature impedes the comprehension and application of findings. To address this gap, we conducted a systematic review focusing on lean individuals with steatotic liver disease. This review interprets the new approach, introducing the term metabolic dysfunction-associated fatty liver disease in alignment with current literature. We aim to enhance the understanding of steatotic liver disease in lean populations, contributing to a precise approach in research and clinical settings.
Publish Date	2024-03-27 13:28
Citation	Sato-Espinoza K, Chotiprasidhi P, Huaman MR, Díaz Ferrer J. Update in lean metabolic dysfunction-associated steatotic liver disease. World J Hepatol 2024; 16 (3): 452-464
URL	https://www.wjgnet.com/1948-5182/full/v16/i3/452.htm
DOI	https://dx.doi.org/10.4254/wjh.v16.i3.452

Full Article (PDF)	WJH-16-452-with-cover.pdf
PRISMA 2009 Checklist	91259-PRISMA 2009 Checklist.pdf
Manuscript File	91259_Auto_Edited-LJH-YJP.docx
Answering Reviewers	91259-Answering reviewers.pdf
Audio Core Tip	91259-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	91259-Conflict-of-interest statement.pdf
Copyright License Agreement	91259-Copyright license agreement.pdf
Peer-review Report	91259-Peer-review(s).pdf
Scientific Misconduct Check	91259-Bing-Liu JH-2.png
Scientific Misconduct Check	91259-CrossCheck.png
Scientific Editor Work List	91259-Scientific editor work list.pdf
CrossCheck Report	91259-CrossCheck report.pdf